Navigation Links
$1,700,000 Funding of NeoStem's Very Small Embryonic-Like Stem Cells Being Developed to Treat Osteoporosis Recommended by the Department of Defense Peer Reviewed Medical Research Program
Date:1/13/2011

NEW YORK, Jan. 13, 2011 /PRNewswire/ -- NeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, today announced that its FY2010 Technology/Therapeutic Development Award application number PR101055 has been recommended for funding by the Department of Defense (DOD) Peer Reviewed Medical Research Program (PRMRP) of the Office of the Congressionally Directed Medical Research Programs (CDMRP).  

The $1,700,000 award, which the Company will receive upon completion of the award process, will be applied towards funding the Company's proposal to continue a strategy aimed at employing the Company's VSEL™ Technology which uses a unique stem cell population, very small embryonic-like stem cells, to treat osteoporosis and improve bone health.

"The work proposed in this application has the potential to dramatically change the way in which osteoporosis and bone fracture is treated in the military and in the general population," said Dr. Russell Taichman, Professor of Dentistry, Department of Periodontics and Oral Medicine at the University of Michigan's School of Dentistry who will work with the Company on the study.  Dr. Taichman added "Osteoporosis is a major medical condition affecting 75 million people worldwide and causing significant morbidity and mortality in the aging population and the increased incidence of fractures is the major cause of death from osteoporosis. In 2005, the estimated cost burden of fractures due to osteoporosis was $19 billion and that is expected to rise to over $25 billion by the year 2025. In addition to being a major concern for the general healthcare community, osteoporosis and related bone fractures have become a concern for the military with significant loss of duty time across all branches of the military due to related stress fractures."

'/>"/>
SOURCE NeoStem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Federal Funding Awarded to Test Antimicrobial Properties of Copper Metals
2. Prostate Cancer Treatment Centre Receives Funding for Clinical Trials
3. U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSCs DVC and Baxter
4. amfAR Announces Funding for HIV Services and Research Aimed at Men Who Have Sex With Men in Developing Countries
5. NanoBio(R) Corporation Completes $30 Million in Equity Funding by Meeting Key Development Milestones
6. Carpet One Floor & Home Continues Making Dramatic Strides in Funding Breast Cancer Research and Awareness
7. Major Deficiencies in Design; Funding of Clinical Trials Affects Future of Scientific Innovation
8. California Stem Cell Agency Exaggerated Its Role in Funding Key Research
9. Continued Funding to Help Advance Exciting Moment in Diabetes Research
10. Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development
11. Vical Receives $6.3 Million Payment for Continued Funding of Allovectin-7(R) Phase 3 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , June 30, 2015 ... ) has announced the addition of the ... report to their offering. This ... biomedicine. Photoacoustic imaging is a safe, non-invasive, ... advantages and represents a great alternative to ...
(Date:7/7/2015)... VIEJO, Calif. , July 7, 2015 /PRNewswire/ ... company focused on developing innovative devices for the ... R. Michael Kleine has joined its Board ... over 25 years of medical device and healthcare ... biomedical companies where he has commercialized numerous leading-edge ...
(Date:7/7/2015)... Accelovance, Inc. (Accelovance), a global contract ... General Medicine announced the completion of enrollment and ... Therapeutics, Inc. for the Phase 3 trial of ... SUSTOL® (granisetron injection, extended release) as part of ... receptor antagonist fosaprepitant and IV corticosteroid dexamethasone ...
Breaking Medicine Technology:Worldwide Biomedical Photoacoustic Imaging Patent Landscape Report 2015 2Worldwide Biomedical Photoacoustic Imaging Patent Landscape Report 2015 3Sequent Medical Appoints Mike Kleine to its Board of Directors 2Sequent Medical Appoints Mike Kleine to its Board of Directors 3Accelovance Completes Trial Enrollment and Delivery of Clinical Data for Heron Therapeutics' Phase 3 Trial 2
... a subsidiary of Kyowa Hakko Kirin Co. Ltd. (KHK), ... the U.S. Food and Drug Administration (FDA) has approved ... and Mitigation Strategy) Access program. This new REMS is ... ABSTRAL ® (fentanyl) sublingual tablets, an ...
... 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. ... pharmaceutical company that specializes in patented biopharmaceutical ... and active pharmaceutical ingredients (API) today announced ... Chengdu Tianyin Pharmaceutical Co., Ltd,s ("Chengdu Tianyin") ...
Cached Medicine Technology:FDA Approves Shared REMS (Risk Evaluation and Mitigation Strategy) Program for all TIRF (Transmucosal Immediate Release Fentanyl) Pain Treatments 2FDA Approves Shared REMS (Risk Evaluation and Mitigation Strategy) Program for all TIRF (Transmucosal Immediate Release Fentanyl) Pain Treatments 3FDA Approves Shared REMS (Risk Evaluation and Mitigation Strategy) Program for all TIRF (Transmucosal Immediate Release Fentanyl) Pain Treatments 4FDA Approves Shared REMS (Risk Evaluation and Mitigation Strategy) Program for all TIRF (Transmucosal Immediate Release Fentanyl) Pain Treatments 5FDA Approves Shared REMS (Risk Evaluation and Mitigation Strategy) Program for all TIRF (Transmucosal Immediate Release Fentanyl) Pain Treatments 6TPI Receives Approval for High Tech Enterprise Status 2
(Date:7/7/2015)... ... July 07, 2015 , ... Healthpointe is ... team. Dr. Alupay, an anesthesiologist and pain management specialist, will be evaluating and treating ... as neurological conditions. , After receiving his Bachelor of Science in Biology from the ...
(Date:7/7/2015)... ... 07, 2015 , ... Parents and guardians of teenagers or young adults will ... holistic treatment center for drug and alcohol abuse located in Southwest Michigan. A recently ... shown a significant increase in the “club drug” use among high school seniors. The ...
(Date:7/7/2015)... ... 07, 2015 , ... FSAstore.com today announced the launch of its ... makes it simple to use, spend and manage HSA funds with innovative tools including ... , According to a report by Devenir , approximately 13.8 million Americans have ...
(Date:7/7/2015)... ... July 07, 2015 , ... With a new community program in the San ... and announced a new charity campaign to raise funds in support of programs for ... which was created especially to care for the special needs of our soldiers. ...
(Date:7/7/2015)... (PRWEB) , ... July 07, ... ... full-service public relations, marketing, and creative design firm, today announced that TimberNook ... public relations and social media campaign, content strategy, and marketing launch package ...
Breaking Medicine News(10 mins):Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 3Health News:A Forever Recovery Releases New Information on “Club Drugs” and Tips for Parents of Teens and Young Adults 2Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 2Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 3Health News:Clear Insurance Group and Nonprofit Soldiers’ Angels Initiate New Charity Campaign in San Antonio, TX to Provide Aid and Comfort for Veterans 2Health News:Clear Insurance Group and Nonprofit Soldiers’ Angels Initiate New Charity Campaign in San Antonio, TX to Provide Aid and Comfort for Veterans 3Health News:TimberNook Selects Calypso Communications for PR, Social Media and Content Strategy 2
... Surgical Company (Nasdaq: STAA ), a leading ... today announced the approval of the KS-Ni Preloaded Silicone ... , , The KS-Ni Preloaded Silicone IOL Injector ... silicone IOL through an incision size of 2.6 mm ...
... ... results of the clinical study that was performed using the Bariatric Advantage High Protein ... on Obesity (ECO). , ... Amsterdam, Holland (Vocus) June 17, 2009 -- Bariatric Advantage presented the results of ...
... ... choosing an alcohol rehab centre. , ... UK (PRWEB) June 17, 2009 -- Linwood Group announce that there is no doubt that a ... struggling with drink on the road to recovery. Having treatment in a residential rehab centre offers ...
... ... select group of leading cardiovascular disease centers in the United States exploring the efficacy ... for the treatment of patients with advanced congestive heart failure (CHF) who are on ... ...
... says new leader of American medicine , , CHICAGO, ... from Bryan, Texas, was inaugurated today as the 164th president ... most influential physician organization. , , (Logo: ... his inaugural address as AMA president, Dr. Rohack spoke to ...
... and Philadelphia Business Journal to sponsor and present health ... Americans spend more than half of their ... many employers are looking for ways to help stem the increases ... Business Journal, Independence Blue Cross (IBC) is urging area business leaders ...
Cached Medicine News:Health News:STAAR Surgical Receives Japanese Clearance for the KS-Ni Preloaded IOL Injector System 2Health News:STAAR Surgical Receives Japanese Clearance for the KS-Ni Preloaded IOL Injector System 3Health News:Bariatric Advantage High Protein Meal Replacement Clinical Study Presented at European Congress on Obesity 2Health News:Linwood Group Research Suggests 3 Questions Everyone Should Ask When Choosing an Alcoholic Residential Centre 2Health News:AGH Joins Select Group of Medical Centers in Study of Promising New Technology for Treatment of Heart Failure 2Health News:AGH Joins Select Group of Medical Centers in Study of Promising New Technology for Treatment of Heart Failure 3Health News:AGH Joins Select Group of Medical Centers in Study of Promising New Technology for Treatment of Heart Failure 4Health News:AMA Inaugurates J. James Rohack as President 2Health News:Employee Health and Reducing Health Care Costs Focus of Working Wellness Expo June 17 2Health News:Employee Health and Reducing Health Care Costs Focus of Working Wellness Expo June 17 3
Rsch color coded Guedel airways offer our best value on oropharyngeal airways. They uniquely combine color coding for size and flexible material without a premium price. Color coded airways are latex...
New - Color Coded Berman Airways. A simple idea makes size identification easier for you., ,Premium upgrade without a premium price. Color Coded Berman airways are latex-free., ,Plastic. Single use...
... uncuffed endotracheal tubes are available ... in standard or precut lengths., ... pediatric uncuffed endotracheal tubes are ... with a radiopaque blue line ...
... Line® uncuffed endotracheal tubes are ... styles, in standard or precut ... and pediatric uncuffed endotracheal tubes ... chloride with a radiopaque blue ...
Medicine Products: